Become part of research dedicated to improving the lives of people with osteoarthritis. Explore our active clinical trials to find opportunities to contribute to advancements in treatment, prevention, and care. Together, we can make a difference.
The MaRVeL study
The University of Sydney’s MaRVeL study is testing and researching a new treatment for knee osteoarthritis.
Pentosan Polysulfate Sodium, sold under the brand name Elmiron in Australia, is already approved to treat chronic bladder inflammation. This University of Sydney study aims to find out it can also help improve knee pain in people with knee osteoarthritis and elevated cholesterol.
Study time frame: 6 months
Study commitment: 4-5 in-person visits at Royal North Shore Hospital in St Leonards, Sydney. Open to people from the Sydney area.
Watch a video on the MaRVel Study
The ATLAS Study
In this study researchers from The University of Sydney aim to understand whether a new supplement combination can improve pain in the knee joint in people with knee osteoarthritis.
The supplement combination contains Boswellia serrata extract, pine bark extract, methylsulfonylmethane, piperine and curcumin.
Study time frame: 3 months
Study commitment: Fully remote trial. Open to people from all around Australia.
Watch a video on the ATLAS study
The Osteoarthritis Prevention Study
The University of Sydney’s TOPS study is testing whether diet and exercise can help prevent knee osteoarthritis in women aged 50 years or older.
Knee osteoarthritis is a leading cause of disability among adults. The University of Sydney aims to find out whether lifestyle changes, such as improving diet and increasing physical activity, can reduce the risk of developing knee osteoarthritis.
The study is suitable for people with knee pain.
Watch a video on the TOPS study
Learn more
This website has been independently developed by Arthritis Australia for Australian users. We thank our sponsors for their support for an unrestricted, educational grant to fund its creation.
